Safety and Efficacy of Anti–IL-23 Monoclonal Antibody QX004N for Patients With Psoriasis: A Randomized Clinical Trial.
Uloženo v:
| Název: | Safety and Efficacy of Anti–IL-23 Monoclonal Antibody QX004N for Patients With Psoriasis: A Randomized Clinical Trial. |
|---|---|
| Autoři: | Li, Xiaojiao, Li, Bing, Yang, Deming, Wang, Meng, Li, Qianqian, Wang, Nan, Fang, Min, Liu, Jingrui, Zhang, Hong, Wu, Min, Li, Cuiyun, Zhu, Xiaoxue, Ding, Yanhua, Li, Shanshan |
| Zdroj: | JAMA Dermatology; Mar2025, Vol. 161 Issue 3, p247-255, 9p |
| Databáze: | Complementary Index |
| ISSN: | 21686068 |
|---|---|
| DOI: | 10.1001/jamadermatol.2024.5059 |
Nájsť tento článok vo Web of Science